Description

In This Issue

T.E.N. Winners & Losers

Economic Burden of Mental Disorders in the United States

Evaluating the Cost-Effectiveness of Antidepressant Therapies: Decision Analysis Modeling vs Randomized Clinical Trials

The TEN Profile

Pharmaceutical Complex: James La Rossa Jr.

Serotonin Reuptake Inhibitors: Pharmacoeconomic Cost-Effective Modeling in a University Psychiatric Outpatient Clinic

James La Rossa Jr.: Last Writes

Economic Implications of Pharmacotherapy for Bipolar Disorder: An Update

Letter From the Editor: Myrna M. Weissman, PhD

T.E.N. Cover Essay: C. Everett Koop

The T.E.N. Centerpiece — Weighing the Cost of Disease: Dorothy P. Rice